JP2006504761A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504761A5
JP2006504761A5 JP2004547576A JP2004547576A JP2006504761A5 JP 2006504761 A5 JP2006504761 A5 JP 2006504761A5 JP 2004547576 A JP2004547576 A JP 2004547576A JP 2004547576 A JP2004547576 A JP 2004547576A JP 2006504761 A5 JP2006504761 A5 JP 2006504761A5
Authority
JP
Japan
Prior art keywords
chloro
alkyl
phenyl
acetamide
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004547576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504761A (ja
Filing date
Publication date
Priority claimed from DE10250743A external-priority patent/DE10250743A1/de
Application filed filed Critical
Publication of JP2006504761A publication Critical patent/JP2006504761A/ja
Publication of JP2006504761A5 publication Critical patent/JP2006504761A5/ja
Pending legal-status Critical Current

Links

JP2004547576A 2002-10-31 2003-10-28 Mch拮抗活性を有する新規アミド化合物及びこれらの化合物を含む薬物 Pending JP2006504761A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10250743A DE10250743A1 (de) 2002-10-31 2002-10-31 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
PCT/EP2003/011933 WO2004039764A1 (de) 2002-10-31 2003-10-28 Neue amid-verbindungen mit mch-antagonistischer wirkung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
JP2006504761A JP2006504761A (ja) 2006-02-09
JP2006504761A5 true JP2006504761A5 (https=) 2009-10-08

Family

ID=32115015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004547576A Pending JP2006504761A (ja) 2002-10-31 2003-10-28 Mch拮抗活性を有する新規アミド化合物及びこれらの化合物を含む薬物

Country Status (24)

Country Link
EP (1) EP1558567B1 (https=)
JP (1) JP2006504761A (https=)
KR (1) KR20050065654A (https=)
CN (1) CN1708476A (https=)
AR (1) AR041735A1 (https=)
AT (1) ATE434601T1 (https=)
AU (1) AU2003285306A1 (https=)
BR (1) BR0315797A (https=)
CA (1) CA2504207C (https=)
CO (1) CO5570698A2 (https=)
DE (2) DE10250743A1 (https=)
EA (1) EA009040B1 (https=)
EC (1) ECSP055765A (https=)
ES (1) ES2327329T3 (https=)
HR (1) HRP20050383A2 (https=)
MX (1) MXPA05002865A (https=)
NO (1) NO20050745L (https=)
PE (1) PE20040785A1 (https=)
PL (1) PL376256A1 (https=)
RS (1) RS20050330A (https=)
TW (1) TW200412936A (https=)
UY (1) UY28051A1 (https=)
WO (1) WO2004039764A1 (https=)
ZA (1) ZA200501164B (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592373B2 (en) 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
FR2866880A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-alkylaminee ortho-et/ou meta-substituee, composition de teinture des fibres keratiniques contenant une telle para-phenylenediamine, procedes mettant en oeuvre cette composition et utilisations
US7605176B2 (en) 2004-03-06 2009-10-20 Boehringer Ingelheim International Gmbh β-ketoamide compounds with MCH antagonistic activity
JP2006076990A (ja) * 2004-03-12 2006-03-23 Bayer Cropscience Ag 殺虫性ベンゼンジカルボキサミド類
DE102004017934A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7524862B2 (en) 2004-04-14 2009-04-28 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
KR20090047542A (ko) 2006-08-25 2009-05-12 베링거 인겔하임 인터내셔날 게엠베하 Mch 길항 활성을 갖는 신규한 피리돈 유도체 및 당해 화합물을 포함하는 의약
WO2008069611A1 (en) * 2006-12-08 2008-06-12 Korea Research Institute Of Chemical Technology N-phenylamide derivative, process for the preparation thereof, and composition for preventing or treating ischemic diseases comprising same
WO2008071646A1 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim International Gmbh New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
WO2010015680A1 (en) * 2008-08-07 2010-02-11 Bayer Cropscience Sa Fungicide oxyalkylamide derivatives
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US9452980B2 (en) * 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
US9079880B2 (en) * 2010-07-07 2015-07-14 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
WO2012008549A1 (ja) * 2010-07-15 2012-01-19 武田薬品工業株式会社 複素環化合物
SG192941A1 (en) 2011-02-25 2013-09-30 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
EP4234545A3 (en) 2011-07-29 2023-09-06 Karyopharm Therapeutics Inc. Hydrazide containing nuclear transport modulators and uses thereof
JP6006794B2 (ja) * 2011-07-29 2016-10-12 カリオファーム セラピューティクス,インコーポレイテッド 核内輸送調節因子およびその使用
JP2015512913A (ja) 2012-03-28 2015-04-30 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
WO2013170068A2 (en) 2012-05-09 2013-11-14 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
RU2015106909A (ru) 2012-08-02 2016-09-27 Мерк Шарп И Доум Корп. Антидиабетические трициклические соединения
KR20150118158A (ko) 2013-02-22 2015-10-21 머크 샤프 앤드 돔 코포레이션 항당뇨병 비시클릭 화합물
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
ME03421B (me) 2013-06-21 2020-01-20 Karyopharm Therapeutics Inc 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba
EP3013796B9 (en) 2013-06-27 2020-07-01 LG Chem, Ltd. Biaryl derivatives as gpr120 agonists
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
CN105439914B (zh) * 2014-09-17 2017-07-11 复旦大学 4‑氨酰基苯氧乙酰胺类化合物及其药物用途
BR112017013465A2 (pt) * 2014-12-24 2018-03-06 Lg Chem, Ltd derivado de biarila, e, composição farmacêutica.
JP6533997B2 (ja) * 2014-12-26 2019-06-26 株式会社ヤクルト本社 Znf143阻害活性を有する化合物およびその利用
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
CN108713019B (zh) 2016-03-17 2021-06-15 豪夫迈·罗氏有限公司 具有作为taar的激动剂的活性的5-乙基-4-甲基-吡唑-3-甲酰胺衍生物
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
EP3558298B1 (en) 2016-12-20 2026-03-11 Merck Sharp & Dohme LLC Antidiabetic spirochroman compounds
BR112022000185A2 (pt) 2019-07-10 2022-02-22 Bayer Ag Método de preparação de 2-(fenilimino)-1,3-tiazolidin-4-onas
BR112023015210A2 (pt) 2021-01-29 2023-11-07 Cedilla Therapeutics Inc Inibidores de cdk2 e métodos de uso dos mesmos
CA3225439A1 (en) 2021-06-26 2022-12-29 Cedilla Therapeutics, Inc. Cdk2 inhibitors and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338804A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
EP1218336A2 (en) * 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
EP1299362A4 (en) * 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
US20030022891A1 (en) * 2000-12-01 2003-01-30 Anandan Palani MCH antagonists and their use in the treatment of obesity
CN100548291C (zh) * 2001-10-25 2009-10-14 先灵公司 用于治疗肥胖的mch拮抗剂

Similar Documents

Publication Publication Date Title
JP2006504761A5 (https=)
RU2201927C2 (ru) Амидиновые соединения и фармацевтическая композиция, обладающая фактор ха ингибирующим действием
CA2504207A1 (en) New amide compounds having mch-antagonistic activity and medicaments comprising these compounds
US6939891B2 (en) Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
JP2007528883A5 (https=)
BG64848B1 (bg) Циклични аминопроизводни и използването им като лекарства
RU2005117783A (ru) 1, 5-диарилпиррол-3-карбоксамидные производные и их применение в качестве модуляторов каннабиноидных рецепторов
JP2004508304A5 (https=)
RU2003136097A (ru) Производные фенилпиридинкарбонилпиперазина
JP2005513123A5 (https=)
WO2006112685A1 (en) Neurotherapeutic azole compounds
JP2010521515A5 (https=)
RU97118779A (ru) Производные арилглицинамидов, способ их получения и фармацевтические композиции, содержащие эти соединения
CA2527159A1 (en) 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
JP2005523310A5 (https=)
CA2407149A1 (en) Melanin-concentrating hormone antagonist
HUP0302966A2 (hu) Karboxamid-vegyületek és alkalmazásuk humán 11CBY receptor antagonistákként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
EP0661266A1 (en) Substituted cyclic amine compounds as 5HT2 antagonists
RU2005111974A (ru) Производные пирролидона в качестве ингибиторов маов
JP2010504930A5 (https=)
JP2000504677A (ja) 5ht7レセプター・アンタゴニスト用のスルホンアミド誘導体
WO2004011430A1 (ja) ナトリウムチャネル阻害剤
RU2011127451A (ru) ПРОИЗВОДНЫЕ ТИЕНО[3,2-c]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ РАКА
JPH10279578A5 (https=)